CIRAX | VGWIX | CIRAX / VGWIX | |
Total Expense Ratio | 0.62 | 0.44 | 141% |
Annual Report Gross Expense Ratio | 0.62 | 0.44 | 141% |
Fund Existence | 24 years | 8 years | - |
Gain YTD | 16.806 | 9.404 | 179% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 250 | 3000 | 8% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 120B | 639M | 18,779% |
Annual Yield % from dividends | 2.90 | 3.56 | 82% |
Returns for 1 year | 12.72 | 6.16 | 207% |
Returns for 3 years | 41.29 | 25.07 | 165% |
Returns for 5 years | 57.84 | 21.95 | 264% |
Returns for 10 years | 97.49 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GJS | 22.95 | 0.10 | +0.43% |
Synthetic Fixed-Income Securities STRATS 2006-2 Goldman Sachs Group | |||
DBE | 18.90 | 0.07 | +0.39% |
Invesco DB Energy | |||
VOO | 604.44 | -0.13 | -0.02% |
Vanguard S&P 500 ETF | |||
HTD | 24.51 | -0.10 | -0.41% |
John Hancock Tax-Advantaged Dividend Income Fund | |||
PBE | 70.13 | -1.31 | -1.83% |
Invesco Biotechnology & Genome ETF |